Gen-Probe (GPRO) Shares Fall as WSJ Says Novartis (NVS) No Longer Pursuing Deal
Tweet
Share
E-mailGet Alerts GPRO Hot Sheet
Join SI Premium – FREE
After trading in positive territory for most of this morning's session, shares of Gen-Probe (Nasdaq: GPRO) are now down nearly 4 percent following headlines from the WSJ Novartis (NYSE: NVS) is no longer pursuing the company.
Gen-Probe shares last traded at $61.95.
Gen-Probe shares last traded at $61.95.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein on whether Hershey (HSY) could eventually step up to buy Mondelez (MDLZ)
- Myriad Uranium completes acquisition of Rush Rare Metals
- reAlpha completes $8.5M InstaMortgage acquisition
Create E-mail Alert Related Categories
Mergers and Acquisitions, Momentum Movers, RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
